Valuation: Orion Oyj

Market Cap 1.15TCr 1.32TCr 1.08TCr 984.58Cr 1.86TCr 1,26200Cr 1.88TCr 13TCr 4.94TCr 63TCr 4.97TCr 4.87TCr 2,09800Cr P/E 2026 *
20.3x
P/E 2027 * 17.4x
Enterprise Value 1.14TCr 1.31TCr 1.07TCr 976.9Cr 1.84TCr 1,25200Cr 1.87TCr 12TCr 4.9TCr 63TCr 4.93TCr 4.83TCr 2,08200Cr EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.72x
Free-Float
90.5%
Yield 2026 *
2.38%
Yield 2027 * 2.66%
1 day+0.25%
1 week+1.12%
Current month+1.12%
1 month+16.57%
3 months+15.25%
6 months+11.17%
Current year+28.91%
1 week 79
Extreme 79
82.3
1 month 66.7
Extreme 66.7
82.3
Current year 62.3
Extreme 62.3
82.3
1 year 56.3
Extreme 56.3
82.3
3 years 32.5
Extreme 32.5
82.3
5 years 32.5
Extreme 32.5
82.3
10 years 24.75
Extreme 24.75
82.3
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+1.12% - - 1.33TCr
+1.89%+3.20%+59.70%+165.18% 1,04300Cr
-0.24%+0.45%+50.64%+52.02% 62TCr
-0.95%-5.26%+24.23%+65.08% 44TCr
0.00%+3.20%+46.70%+37.60% 36TCr
+0.58%-1.26%+35.52%+40.54% 29TCr
-1.55%-6.84%+7.20%+8.62% 25TCr
-0.73%+4.44%+42.22%+66.41% 22TCr
-0.24%-11.27%+1.42%-44.69% 20TCr
-0.68%-0.32%+18.66%+66.32% 16TCr
Average -0.44%-2.66%+31.81%+50.79% 39.88TCr
Weighted average by Cap. -0.54%-1.42%+40.67%+77.18%

Financials

2026 *2027 *
Net sales 209.65Cr 241.58Cr 196.31Cr 179.57Cr 339.01Cr 23TCr 343.43Cr 2.3TCr 901.3Cr 11TCr 907.05Cr 887.33Cr 38TCr 236.67Cr 272.73Cr 221.62Cr 202.73Cr 382.72Cr 26TCr 387.71Cr 2.59TCr 1.02TCr 13TCr 1.02TCr 1TCr 43TCr
Net income 56Cr 65Cr 53Cr 48Cr 91Cr 6.2TCr 92Cr 618.36Cr 242.68Cr 3.1TCr 244.22Cr 238.92Cr 10TCr 66Cr 76Cr 62Cr 57Cr 106.79Cr 7.25TCr 108.18Cr 723.42Cr 283.9Cr 3.62TCr 285.71Cr 279.5Cr 12TCr
Net Debt -8.98Cr -10Cr -8.4Cr -7.69Cr -15Cr -985.3Cr -15Cr -98Cr -39Cr -492.29Cr -39Cr -38Cr -1.64TCr -33Cr -38Cr -31Cr -29Cr -54Cr -3.65TCr -55Cr -364.75Cr -143.14Cr -1.83TCr -144.06Cr -140.93Cr -6.08TCr
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
06/26/06 €81.60 +0.25% 3,271
05/26/05 €81.40 +1.50% 11,066
04/26/04 €80.20 +1.26% 5,269
03/26/03 €79.20 -1.86% 3,533
31/26/31 €80.70 0.00% 3,419
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
81.60EUR
Average target price
76.67EUR
Spread / Average Target
-6.05%

Quarterly revenue - Rate of surprise